Delivery Order SPE2DB24D3013-SPE2DB25FFNZU
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Nexlizet 180-10 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $1,216.50, is non-competitive and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. The award represents a single pharmaceutical product delivery under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $2,402.40 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Nexlizet 180-10 mg tablets in quantities of 30 units. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 12, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,256.98 to AmerisourceBergen Drug Corp for NEXLIZET 180-10 MG tablets (30-count units) on July 31, 2025, with an ultimate completion date of August 1, 2025. This competitive award, which did not utilize a set-aside designation, represents a firm fixed-price transaction for pharmaceutical delivery to support federal medical procurement needs. The order is being fulfilled from AmerisourceBergen's Corporate Office location in...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for NEXLIZET 180-10 MG tablets in 30-count units, valued at $2,205.61. This firm fixed-price delivery order, with an ultimate completion date of August 1, 2025, represents a non-set-aside competitive award to the pharmaceutical distributor's Corporate Office division. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $1,621.05 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Nexlizet 180-10 mg tablets (30-count units). This is a non-set-aside, competitively awarded contract with an ultimate completion date of August 1, 2025, and performance to be fulfilled from the vendor's Conshohocken, Pennsylvania location. The delivery order represents a child contract executed under AmerisourceBergen's larger Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,364.32, is for the supply of the drug NEXLIZET 180-10 MG TABLET to support U.S. military and federal healthcare programs. It is a firm-fixed-price contract with an ultimate completion date of August 15, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $1,250.17 delivery order to AmerisourceBergen Drug Corp for 30 tablets of Nexletol 180 mg on August 8, 2025, with completion targeted for August 11, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is the contractor's...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $1,768.56 with a firm fixed price. It covers the supply of NEXLIZET 180-10 MG TABLET for the DLA, with an ultimate completion date of April 1, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award, valued at $1,473.02, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NEXLIZET 180-10 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of July 19, 2024 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside award. AmerisourceBergen holds a significant...
- The Defense Logistics Agency awarded a $1,988.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Nexletol 180 mg tablets in quantities of 30 units. This is a non-set-aside delivery order with an ultimate completion date of September 11, 2025, and will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFNZUDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,266.43 to AmerisourceBergen Drug Corp for the supply of Nexlizet 180-10 mg tablets (30-unit package) on August 5, 2025, with completion targeted for August 6, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and is performed at the contractor's location in Conshohocken, Pennsylvania. As a child contract action under AmerisourceBergen's larger contract vehicle, this delivery order fulfills critical pharmaceutical supply needs within the federal medical supply chain supporting military and veteran healthcare systems. This award is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, has demonstrated significant capability in meeting federal procurement requirements through competitive contracting, serving customers including the Defense Health Agency and U.S. Coast Guard across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 8/5/25 |